Prior breast cancer studies reported down-regulation of EGR1 is linked to unfavorable prognosis29, while up-regulation of STC2 reduces cell proliferation, inhibits epithelial-mesenchymal transition, and is associated with late rather than early recurrence30. This evidence concerns the gene STC2 and breast cancer.